Literature DB >> 15499064

Decreased cortisol response to insulin induced hypoglycaemia in asthmatics treated with inhaled fluticasone propionate.

P Mahachoklertwattana1, K Sudkronrayudh, C Direkwattanachai, L Choubtum, C Okascharoen.   

Abstract

AIMS: To assess adrenal function in asthmatic children treated with inhaled fluticasone propionate for up to 16 weeks.
METHODS: Children with asthma and bronchial hyperresponsiveness to inhaled methacholine were treated with inhaled fluticasone 250-750 microg/day via Volumatic spacer. The insulin tolerance test (ITT) was performed to assess adrenal function.
RESULTS: Eighteen asthmatic patients (10 boys, 8 girls), aged 7-17 years received inhaled fluticasone therapy at a median dose of 477 microg/m2 per day for 5-16 weeks. Adrenal suppression, defined as 60 minute serum cortisol less than 500 nmol/l, was found in 9 of 18 children. Following the ITT, the median basal and 60 minute serum cortisol concentrations of the suppressed group were 135.0 and 350.0 nmol/l, respectively; the corresponding values for the unsuppressed group were 242.2 and 564.7 nmol/l. Repeat ITT in the suppressed group 2-3 months after discontinuation of fluticasone revealed that all patients had a 60 minute serum cortisol greater than 500 nmol/l.
CONCLUSION: After therapy for asthma with inhaled fluticasone at approximately 500 microg daily for up to 16 weeks, half the children had evidence of adrenal suppression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15499064      PMCID: PMC1719701          DOI: 10.1136/adc.2002.020560

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  31 in total

1.  Symptomatic adrenal insufficiency presenting with hypoglycaemia in children with asthma receiving high dose inhaled fluticasone propionate.

Authors:  A J Drake; R J Howells; J P H Shield; A Prendiville; P S Ward; E C Crowne
Journal:  BMJ       Date:  2002-05-04

2.  Safety of the insulin tolerance test.

Authors:  P J Galloway; E McNeill; W F Paterson; M D C Donaldson
Journal:  Arch Dis Child       Date:  2002-10       Impact factor: 3.791

3.  Hazards of pharmacological tests of growth hormone secretion in childhood.

Authors:  A Shah; R Stanhope; D Matthew
Journal:  BMJ       Date:  1992-01-18

Review 4.  Endocrine and neurophysiologic responses of the pituitary to insulin-induced hypoglycemia: a review.

Authors:  H R Fish; B Chernow; J T O'Brian
Journal:  Metabolism       Date:  1986-08       Impact factor: 8.694

5.  Dose response with fluticasone propionate on adrenocortical activity and recovery of basal and stimulated responses after stopping treatment.

Authors:  A M Wilson; E J Sims; B J Lipworth
Journal:  Clin Endocrinol (Oxf)       Date:  1999-03       Impact factor: 3.478

6.  Symptomatic adrenal insufficiency during inhaled corticosteroid treatment.

Authors:  L Patel; J K Wales; M S Kibirige; A A Massarano; J M Couriel; P E Clayton
Journal:  Arch Dis Child       Date:  2001-10       Impact factor: 3.791

7.  Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom.

Authors:  G R G Todd; C L Acerini; R Ross-Russell; S Zahra; J T Warner; D McCance
Journal:  Arch Dis Child       Date:  2002-12       Impact factor: 3.791

Review 8.  Normal and abnormal function of the hypothalamic-pituitary-adrenocortical system in man.

Authors:  D H Streeten; G H Anderson; T G Dalakos; D Seeley; J S Mallov; R Eusebio; F S Sunderlin; S Z Badawy; R B King
Journal:  Endocr Rev       Date:  1984       Impact factor: 19.871

9.  Adrenal suppression from high-dose inhaled fluticasone propionate in children with asthma.

Authors:  D Sim; A Griffiths; D Armstrong; C Clarke; C Rodda; N Freezer
Journal:  Eur Respir J       Date:  2003-04       Impact factor: 16.671

10.  Methacholine bronchial challenge in children.

Authors:  G G Shapiro; C T Furukawa; W E Pierson; C W Bierman
Journal:  J Allergy Clin Immunol       Date:  1982-04       Impact factor: 10.793

View more
  6 in total

1.  Long-Term Cortisol Concentration in Scalp Hair of Asthmatic Children Using Inhaled Corticosteroids: A Case-Control Study.

Authors:  Maaike P Smit; Ed H G van Leer; Gerard Noppe; Yolanda B de Rijke; Dieneke Kramer van Driel; Erica L T van den Akker
Journal:  Horm Res Paediatr       Date:  2017-07-14       Impact factor: 2.852

2.  Suppression of HPA axis in adults taking inhaled corticosteroids.

Authors:  J R Greenfield; K Samaras
Journal:  Thorax       Date:  2006-03       Impact factor: 9.139

3.  Adrenocortical suppression increases the risk of relapse in nephrotic syndrome.

Authors:  Asiri S Abeyagunawardena; Peter Hindmarsh; Richard S Trompeter
Journal:  Arch Dis Child       Date:  2007-02-06       Impact factor: 3.791

4.  Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone.

Authors:  J Paton; E Jardine; E McNeill; S Beaton; P Galloway; D Young; M Donaldson
Journal:  Arch Dis Child       Date:  2006-03-23       Impact factor: 3.791

5.  Adrenal suppression: A practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy.

Authors:  Alexandra Ahmet; Harold Kim; Sheldon Spier
Journal:  Allergy Asthma Clin Immunol       Date:  2011-08-25       Impact factor: 3.406

6.  CSACI position statement: systemic effect of inhaled corticosteroids on adrenal suppression in the management of pediatric asthma.

Authors:  Karine Issa-El-Khoury; Harold Kim; Edmond S Chan; Tim Vander Leek; Francisco Noya
Journal:  Allergy Asthma Clin Immunol       Date:  2015-03-14       Impact factor: 3.406

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.